- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01872312
Spiration IBV® Valve System and Spiration Airway Sizing Kit
June 24, 2022 updated by: Ohio State University
The Humanatarian Use of the Spiration IBV® Valve System and Spiration Airway Sizing Kit for Use in Patients at The Ohio State University Medical Center.
This procedure allows patients to use the Humanitarian Use Device, IBV® Valve System.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
IBV® Valve System The Spiration® IBV Valve System is a device to control prolonged air leaks of the lung, or significant air leaks that are likely to become prolonged air leaks following lobectomy, segmentectomy, or lung volume reduction surgery (LVRS).
An air leak present on postoperative day 7 is considered prolonged unless present only during forced exhalation or cough.
An air leak present on day 5 should be considered for treatment if it is: 1) continuous, 2) present during normal inhalation phase of inspiration, or 3) present upon normal expiration and accompanied by subcutaneous emphysema or respiratory compromise.
IBV Valve System use is limited to 6 weeks per prolonged air leak.
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- OSUMC
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Unresolved BPF
- Not candidate for surgical repair
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: treatment
Loading IBV® Valve System
|
treat BPF
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
resolution of BPF (Bronchopleural Fistulae)
Time Frame: 6 weeks
|
expected resolution of BPF (Bronchopleural Fistulae) in three weeks
|
6 weeks
|
resolutin of BPF
Time Frame: 6 weeks
|
anticipated the with the use of valves the BPF would improve and the valves can be removed in 6 weeks
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
March 25, 2012
Primary Completion (ACTUAL)
February 14, 2014
Study Completion (ACTUAL)
February 14, 2014
Study Registration Dates
First Submitted
April 10, 2013
First Submitted That Met QC Criteria
June 6, 2013
First Posted (ESTIMATE)
June 7, 2013
Study Record Updates
Last Update Posted (ACTUAL)
June 30, 2022
Last Update Submitted That Met QC Criteria
June 24, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2012H0033
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Management of BPF (Bronchopleural Fistulae)
-
Mayo ClinicLivaNovaCompletedManagement of AnticoagulationUnited States
-
N.M.B. Medical Applications LtdUnknownObstructive Lesions of Arteriovenous Dialysis FistulaeIsrael
-
National and Kapodistrian University of AthensCompletedAnatomic Features of the Neck and Preoperative Tests as Predictive Markers of Difficult LaryngoscopyAirway Management | Predictive Value of Tests
-
Brigham and Women's HospitalAgency for Healthcare Research and Quality (AHRQ)CompletedManagement of Actionable Test Results (ATRs)United States
-
Medical University of SilesiaCompletedAirway Management | Predictive Value of TestsPoland
-
Issam TanoubiCompletedPerformance of Non-anesthesiologists Residents for the Management of Sedation's Complications
-
Fundació Institut de Recerca de l'Hospital de la...CompletedSelf Management of Oral Anticoagulation With VKA TherapySpain
-
John LaffeyCompletedPerformance and Safety of an Airway Management DeviceIreland
-
University College Hospital GalwayCompletedPerformance and Safety of an Airway Management DeviceIreland
-
Ottawa Hospital Research InstituteCompletedFocus of Study is Teaching Crisis Resource ManagementCanada
Clinical Trials on treatment with valves (The Spiration® IBV Valve System)
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
Spiration, Inc.CompletedProlonged Air LeakUnited States
-
Spiration, Inc.Completed
-
HLT Inc.WithdrawnAortic RegurgitationUnited States
-
Abbott Medical DevicesTerminated
-
Thubrikar Aortic Valve, Inc.KCRIRecruitingSevere Aortic StenosisPoland
-
Medical University of ViennaCompletedMacular Edema | Proliferative Diabetic RetinopathyAustria
-
Acandis GmbHTerminatedAcute Ischemic Stroke | Intracranial StenosisGermany
-
Peijia Medical Technology (Suzhou) Co., Ltd.General Hospital of Shenyang Military Region; Shanghai Zhongshan Hospital; China... and other collaboratorsCompleted
-
Treace Medical Concepts, Inc.RecruitingHallux Valgus | Metatarsus AdductusUnited States